Ravi
★    

India,
2010-08-10 11:22
(5803 d 08:56 ago)

Posting: # 5751
Views: 4,664
 

 Draft Guidance on Sevelamer Carbonate [Regulatives / Guidelines]

Dear All,

I want some clearity about "Draft Guidance on Sevelamer Carbonate" (link provided for reference)
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm089620.pdf

My question is related to section 1 i.e. In-vitro equilibrium binding.

In this section it is mentioned that 90% CI should be calulated for k2 with the acceptance criteria of 80% to 125%. Please provide some more clarity about the above highlightened line.
90% CI should be calculated form what - Mean, Geo. Mean or for T/R ratio
I just wanted to know how this calculation is to be performed.

Reference for the calulation for k1 and k2 can be found from this link
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TGX-45BCTJG-1&_user=6968900&_coverDate=06%2F20%2F2002&am...;_ct=1635&_acct=C000067714&_version=1&_urlVersion=0&_userid=6968900&md5=55836e6b72e078246382082891985e26

Thanks & Regards
Ravi Pandey
govardhanpillari
☆    

India,
2010-09-04 11:08
(5778 d 09:10 ago)

@ Ravi
Posting: # 5886
Views: 2,804
 

 Draft Guidance on Sevelamer Carbonate

Dear Ravi,

❝ In this section it is mentioned that 90% CI should be calulated for k2 with

❝ the acceptance criteria of 80% to 125%.


First of all, the guidance says that 90% CI should be calulated for k2 with the acceptance criteria of 80% to 120%. not the 80% to 125%.

❝ 90% CI should be calculated form what - Mean, Geo. Mean or for T/R ratio

❝ I just wanted to know how this calculation is to be performed.


The 90% confidence intervals will be constructed for the ratio of the mean of capacity constant (K2)

Regards,

PGR


Edit: Standard quotes restored. [Helmut]

Govardhan.P
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
348 visitors (0 registered, 348 guests [including 18 identified bots]).
Forum time: 20:18 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5